Cargando…

Gafchromic film dosimetry of a new HDR [Formula: see text] brachytherapy source

High‐dose‐rate (HDR) brachytherapy is a popular modality for treating cancers of the prostate, cervix, endometrium, breast, skin, bronchus, esophagus, and head and neck as well as soft‐tissue sarcomas. Because of different source designs and licensing issues, there is a need for specific dosimetry d...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayoobian, Navid, Asl, Akbar Sarabi, Poorbaygi, Hosein, Javanshir, Mohammad Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874862/
https://www.ncbi.nlm.nih.gov/pubmed/27074483
http://dx.doi.org/10.1120/jacmp.v17i2.6005
_version_ 1783310247869284352
author Ayoobian, Navid
Asl, Akbar Sarabi
Poorbaygi, Hosein
Javanshir, Mohammad Reza
author_facet Ayoobian, Navid
Asl, Akbar Sarabi
Poorbaygi, Hosein
Javanshir, Mohammad Reza
author_sort Ayoobian, Navid
collection PubMed
description High‐dose‐rate (HDR) brachytherapy is a popular modality for treating cancers of the prostate, cervix, endometrium, breast, skin, bronchus, esophagus, and head and neck as well as soft‐tissue sarcomas. Because of different source designs and licensing issues, there is a need for specific dosimetry dataset for each HDR source model. The main objective of the present work is to measure 2D relative dose distribution around a new prototype [Formula: see text] source, referred to as IRAsource‐HDR, in PMMA phantom in the framework of AAPM TG‐43 and TG‐55 recommendations for radial distances of 0.5 cm to 4 cm. Radiochromic films (RCFs) Gafchromic EBT and HD‐810 were used for measurements. The dose rate constant, Λ, of the source was determined to be [Formula: see text] , and [Formula: see text] using EBTRCF, HD‐810 RCF, and Monte Carlo (MC) simulation, respectively. The results obtained in this study are in good agreement with previously published data for HDR interstitial [Formula: see text] ‐HDR sources with a maximum discrepancy of [Formula: see text]. An acceptable agreement (within [Formula: see text]) between MC calculations and RCFs measurements showed that HD‐810 RCF dosimetry is as good as EBTRCF, within HDR brachytherapy, and justifies the use of specific data for this new source. These data could be used as a benchmark for dose calculations in the conventional brachytherapy treatment planning systems. PACS number(s): 87.56.bg
format Online
Article
Text
id pubmed-5874862
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-58748622018-04-02 Gafchromic film dosimetry of a new HDR [Formula: see text] brachytherapy source Ayoobian, Navid Asl, Akbar Sarabi Poorbaygi, Hosein Javanshir, Mohammad Reza J Appl Clin Med Phys Radiation Oncology Physics High‐dose‐rate (HDR) brachytherapy is a popular modality for treating cancers of the prostate, cervix, endometrium, breast, skin, bronchus, esophagus, and head and neck as well as soft‐tissue sarcomas. Because of different source designs and licensing issues, there is a need for specific dosimetry dataset for each HDR source model. The main objective of the present work is to measure 2D relative dose distribution around a new prototype [Formula: see text] source, referred to as IRAsource‐HDR, in PMMA phantom in the framework of AAPM TG‐43 and TG‐55 recommendations for radial distances of 0.5 cm to 4 cm. Radiochromic films (RCFs) Gafchromic EBT and HD‐810 were used for measurements. The dose rate constant, Λ, of the source was determined to be [Formula: see text] , and [Formula: see text] using EBTRCF, HD‐810 RCF, and Monte Carlo (MC) simulation, respectively. The results obtained in this study are in good agreement with previously published data for HDR interstitial [Formula: see text] ‐HDR sources with a maximum discrepancy of [Formula: see text]. An acceptable agreement (within [Formula: see text]) between MC calculations and RCFs measurements showed that HD‐810 RCF dosimetry is as good as EBTRCF, within HDR brachytherapy, and justifies the use of specific data for this new source. These data could be used as a benchmark for dose calculations in the conventional brachytherapy treatment planning systems. PACS number(s): 87.56.bg John Wiley and Sons Inc. 2016-03-08 /pmc/articles/PMC5874862/ /pubmed/27074483 http://dx.doi.org/10.1120/jacmp.v17i2.6005 Text en © 2016 The Authors. This is an open access article under the terms of the http://creativecommons.org/licenses/by/3.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Radiation Oncology Physics
Ayoobian, Navid
Asl, Akbar Sarabi
Poorbaygi, Hosein
Javanshir, Mohammad Reza
Gafchromic film dosimetry of a new HDR [Formula: see text] brachytherapy source
title Gafchromic film dosimetry of a new HDR [Formula: see text] brachytherapy source
title_full Gafchromic film dosimetry of a new HDR [Formula: see text] brachytherapy source
title_fullStr Gafchromic film dosimetry of a new HDR [Formula: see text] brachytherapy source
title_full_unstemmed Gafchromic film dosimetry of a new HDR [Formula: see text] brachytherapy source
title_short Gafchromic film dosimetry of a new HDR [Formula: see text] brachytherapy source
title_sort gafchromic film dosimetry of a new hdr [formula: see text] brachytherapy source
topic Radiation Oncology Physics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874862/
https://www.ncbi.nlm.nih.gov/pubmed/27074483
http://dx.doi.org/10.1120/jacmp.v17i2.6005
work_keys_str_mv AT ayoobiannavid gafchromicfilmdosimetryofanewhdrformulaseetextbrachytherapysource
AT aslakbarsarabi gafchromicfilmdosimetryofanewhdrformulaseetextbrachytherapysource
AT poorbaygihosein gafchromicfilmdosimetryofanewhdrformulaseetextbrachytherapysource
AT javanshirmohammadreza gafchromicfilmdosimetryofanewhdrformulaseetextbrachytherapysource